MedPath

Improving Care Through Improv: Promoting Mastery in the Moment

Not Applicable
Completed
Conditions
Caregiver Burden
Registration Number
NCT05996718
Lead Sponsor
Georgia State University
Brief Summary

The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Forty-three informal caregivers will be involved in testing the training program. These individuals will be assigned to groups of between 8 to12 caregivers and take part in weekly 2-hour sessions held over a 4-week period. These caregivers will be taught improvisational (improv) theater skills, which involves being in the moment, self-awareness, and responsiveness to others. This group also will be asked to answer surveys questions about themselves and the person receiving care at three timepoints and invited to provide feedback on their training experiences.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • Actively engaged in the care of community-dwelling persons living with moderate dementia (4 or 5 on a 7-point dementia-staging scale) who is not likely to be institutionalized within the next 6 months
  • Able to attend at least 3 of the 4 in-person sessions
  • Ability to communicate in English
Exclusion Criteria

Potential participants were excluded if they did not meet the above criteria or anticipated moving their person to a skilled nursing facility within the next 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Pearlin Mastery, Loss, and Competence: Caregiver Competence Subscaleat baseline, upon training completion (Week 4), and three months post baseline.

4-item Likert-type scale; scores range from 4 to 16 with higher scores indicating greater feelings of competence.

Secondary Outcome Measures
NameTimeMethod
Center for Epidemiological Studies-Depression Scaleat baseline, upon training completion (Week 4), and three months post baseline.

20-item Likert-type scale. Scores range from 0 to 60 with higher scores indicating greater depression.

State-Trait Anxiety Inventoryat baseline, upon training completion (Week 4), and three months post baseline.

20-item Likert-type scale. Scores range from 20 to 80 with higher scores indicating greater anxiety.

Zarit Burden Inventoryat baseline, upon training completion (Week 4), and three months post baseline.

22-item scale with 4-point Likert scale responses. Scores range from 0 to 88 with higher scores indicating greater burden.

Revised Memory and Behavioral Problems Checklist - FREQUENCYat baseline, upon training completion (Week 4), and three months post baseline.

24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.

Quality of Life-Alzheimer's Disease Scaleat baseline, upon training completion (Week 4), and three months post baseline.

13 items with a 4-point Likert scale. Scores range from 13 to with 52 with higher scores indicating greater quality of life among persons living with dementia

Revised Memory and Behavioral Problems Checklist - REACTIONat baseline, upon training completion (Week 4), and three months post baseline.

24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.

Perceived Stress Scaleat baseline, upon training completion (Week 4), and three months post baseline.

14-item Likert-type scale. Scores range from 0 to 56 with higher scores indicating greater stress.

Trial Locations

Locations (1)

Georgia State University

🇺🇸

Atlanta, Georgia, United States

Georgia State University
🇺🇸Atlanta, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.